Ethan Rubinstein

11.4k total citations
140 papers, 6.8k citations indexed

About

Ethan Rubinstein is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Ethan Rubinstein has authored 140 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Epidemiology, 56 papers in Infectious Diseases and 39 papers in Pharmacology. Recurrent topics in Ethan Rubinstein's work include Antibiotics Pharmacokinetics and Efficacy (39 papers), Antimicrobial Resistance in Staphylococcus (36 papers) and Pneumonia and Respiratory Infections (29 papers). Ethan Rubinstein is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (39 papers), Antimicrobial Resistance in Staphylococcus (36 papers) and Pneumonia and Respiratory Infections (29 papers). Ethan Rubinstein collaborates with scholars based in Canada, Israel and United States. Ethan Rubinstein's co-authors include James A. Karlowsky, George G. Zhanel, Daryl J. Hoban, Yoav Keynan, Philippe Lagacé‐Wiens, Alfred S. Gin, Sheryl Zelenitsky, Frank Schweizer, Heather J. Adam and Marin H. Kollef and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

Ethan Rubinstein

138 papers receiving 6.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ethan Rubinstein Canada	45	2.4k	2.4k	1.8k	1.8k	1.0k	140	6.8k
Louis D. Saravolatz United States	41	2.3k 1.0×	3.3k 1.4×	1.7k 1.0×	1.4k 0.8×	1.3k 1.2×	174	7.5k
Emilia Cercenado Spain	43	2.6k 1.1×	2.5k 1.0×	1.6k 0.9×	771 0.4×	995 0.9×	245	6.5k
Richard Quintiliani United States	42	2.6k 1.1×	1.9k 0.8×	1.9k 1.1×	3.4k 1.9×	749 0.7×	260	6.9k
Alasdair MacGowan United Kingdom	47	2.3k 0.9×	2.2k 0.9×	2.8k 1.6×	2.8k 1.6×	1.3k 1.2×	284	8.4k
Winfried V. Kern Germany	55	3.1k 1.3×	3.0k 1.3×	2.6k 1.5×	1.4k 0.8×	1.6k 1.5×	289	10.1k
James J. Rahal United States	42	2.3k 1.0×	1.8k 0.8×	3.1k 1.8×	1.6k 0.9×	816 0.8×	109	6.5k
Javier Garau Spain	53	4.8k 2.0×	2.3k 1.0×	2.2k 1.2×	1.4k 0.8×	1.3k 1.2×	208	10.9k
David M. Shlaes United States	47	1.9k 0.8×	2.6k 1.1×	2.6k 1.5×	1.5k 0.9×	2.0k 1.9×	131	8.0k
Douglas J. Biedenbach United States	44	2.0k 0.8×	2.2k 0.9×	2.9k 1.7×	1.9k 1.1×	799 0.8×	153	6.1k
Arne C. Rodloff Germany	38	1.9k 0.8×	1.7k 0.7×	1.5k 0.8×	762 0.4×	708 0.7×	175	5.1k

Countries citing papers authored by Ethan Rubinstein

Since Specialization

Citations

This map shows the geographic impact of Ethan Rubinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ethan Rubinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ethan Rubinstein more than expected).

Fields of papers citing papers by Ethan Rubinstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ethan Rubinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ethan Rubinstein. The network helps show where Ethan Rubinstein may publish in the future.

Co-authorship network of co-authors of Ethan Rubinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Ethan Rubinstein. A scholar is included among the top collaborators of Ethan Rubinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ethan Rubinstein. Ethan Rubinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alfa, Michelle J., et al.. (2016). In vitroevaluation of the effect of linezolid and levofloxacin onBacillus anthracistoxin production, spore formation and cell growth. Journal of Antimicrobial Chemotherapy. 72(2). 417–420. 3 indexed citations

Schneeberg, Amy, Julie A. Bettinger, Shelly McNeil, et al.. (2014). Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation. BMC Public Health. 14(1). 442–442. 60 indexed citations

Rubinstein, Ethan, Martín E. Stryjewski, & Steven L. Barriere. (2014). Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia. Infection and Drug Resistance. 7. 129–129. 10 indexed citations

Barriere, Steven L., Martín E. Stryjewski, G. Ralph Corey, Fredric C. Genter, & Ethan Rubinstein. (2014). Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies. BMC Infectious Diseases. 14(1). 183–183. 32 indexed citations

George, Gautam, et al.. (2013). セフタジジム-アビバクタム: 新規セファロスポリン/β-ラクタマーゼ阻害剤の併用. Drugs. 73(2). 159–177. 1 indexed citations

Zhanel, George G., Phillip Chung, Heather J. Adam, et al.. (2013). Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli. Drugs. 74(1). 31–51. 267 indexed citations

Keynan, Yoav, Rohit K. Singal, Kanwal Kumar, Rakesh C. Arora, & Ethan Rubinstein. (2013). Infective Endocarditis in the Intensive Care Unit. Critical Care Clinics. 29(4). 923–951. 13 indexed citations

Rubinstein, Ethan. (2012). Telavancin in the treatment of invasive Gram-positive infections. 25–25. 2 indexed citations

Maor‬‏, ‪Yasmin, et al.. (2010). Changing parents’ opinions regarding antibiotic use in primary care. European Journal of Pediatrics. 170(3). 359–364. 14 indexed citations

10.

Vinh, Donald C. & Ethan Rubinstein. (2009). Linezolid: a review of safety and tolerability. Journal of Infection. 59. S59–S74. 170 indexed citations

11.

Rubinstein, Ethan. (2008). Telavancin for Treatment of Hospital-Acquired Pneumonia (HAP) Caused by MRSA and MSSA: The ATTAIN Studies. 46th Annual Meeting. 5 indexed citations

12.

Rubinstein, Ethan. (2008). Telavancin for the Treatment of Hospital-Acquired Pneumonia in Severely Ill and Older Patients: The ATTAIN Studies. 46th Annual Meeting. 2 indexed citations

13.

Rubinstein, Ethan. (2008). Staphylococcus aureus bacteraemia with known sources. International Journal of Antimicrobial Agents. 32. S18–S20. 31 indexed citations

14.

Rubinstein, Ethan. (2007). Short antibiotic treatment courses or how short is short?. International Journal of Antimicrobial Agents. 30. 76–79. 36 indexed citations

15.

Rubinstein, Ethan & David Vaughan. (2005). Tigecycline. Drugs. 65(10). 1317–1336. 56 indexed citations

16.

Ben-David, Debby & Ethan Rubinstein. (2002). Appropriate use of antibiotics for respiratory infections: review of recent statements and position papers. Current Opinion in Infectious Diseases. 15(2). 151–156. 16 indexed citations

17.

Weinberger, Miriam, Silvio Pitlik, Dan Gandacu, et al.. (2001). West Nile Fever Outbreak, Israel, 2000: Epidemiologic Aspects. Emerging infectious diseases. 7(4). 686–691. 149 indexed citations

18.

Rubinstein, Ethan & Itzhak Levy. (1999). Acinetobacter spp. and other non-fermentative pathogens causing nosocomial bacteremias. Clinical Microbiology and Infection. 5. 2S29–2S32. 2 indexed citations

19.

Rubinstein, Ethan, et al.. (1998). Lower respiratory tract infections: etiology, current treatment, and experience with fluoroquinolones. Clinical Microbiology and Infection. 4. 2S42–2S50. 10 indexed citations

20.

Rubinstein, Ethan, Andrew B. Onderdonk, & James J. Rahal. (1974). Peritonsillar infection and bacteremia caused by Fusobacterium gonidiaformans. The Journal of Pediatrics. 85(5). 673–675. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact